KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growthKazuhide Nakamura(Takeda (Japan)), Toshiyuki Isoe(Kirin (Japan))Molecular Cancer TherapeuticsDecember 1, 200410.1158/1535-7163.1639.3.12Cited by 66SaveCiteExport RISWatch citationsRelated PapersSynergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication|Oncogenesis|2017|38Panitumumab interaction with<scp>TAS</scp>‐102 leads to combinational anticancer effects via blocking of<scp>EGFR</scp>‐mediated tumor response to trifluridine|Molecular Oncology|2017|22